Unknown

Dataset Information

0

Recent advances in the management of dry age-related macular degeneration: A review.


ABSTRACT: Age-related macular degeneration (AMD), the most important cause of vision loss in elderly people, is a degenerative disorder of the central retina with a multifactorial etiopathology. AMD is classified in dry AMD (d-AMD) or neovascular AMD depending on the presence of choroidal neovascularization. Currently, no therapy is approved for geographic atrophy, the late form of d-AMD, because no treatment can restore the damage of retinal pigment epithelium (RPE) or photoreceptors. For this reason, all treatment approaches in d-AMD are only likely to prevent and slow down the progression of existing atrophy. This review focuses on the management of d-AMD and especially on current data about potential targets for therapies evaluated in clinical trials. Numerous examinations are available in clinics to monitor morphological changes in the retina, RPE and choroid of d-AMD patients. Fundus autofluorescence and optical coherence tomography (OCT) are considered the most useful tools in the diagnosis and follow-up of d-AMD alterations, including the monitoring of atrophy area progression. Instead, OCT-angiography is a novel imaging tool that may add further information in patients affected by d-AMD. Several pathways, including oxidative stress, deposits of lipofuscin, chronic inflammation and choroidal blood flow insufficiency, seem to play an important role in the pathogenesis of d-AMD and represent possible targets for new therapies. A great number of treatments for d-AMD are under investigation with promising results in preliminary studies. However, only few of these drugs will enter the market, offering a therapeutic chance to patients affected by the dry form of AMD and help them to preserve a good visual acuity. Further studies with a long-term follow-up would be important to test the real safety and efficacy of drugs under investigation.

SUBMITTER: Bandello F 

PROVIDER: S-EPMC5428517 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature

altmetric image

Publications

Recent advances in the management of dry age-related macular degeneration: A review.

Bandello Francesco F   Sacconi Riccardo R   Querques Lea L   Corbelli Eleonora E   Cicinelli Maria Vittoria MV   Querques Giuseppe G  

F1000Research 20170309


Age-related macular degeneration (AMD), the most important cause of vision loss in elderly people, is a degenerative disorder of the central retina with a multifactorial etiopathology. AMD is classified in dry AMD (d-AMD) or neovascular AMD depending on the presence of choroidal neovascularization. Currently, no therapy is approved for geographic atrophy, the late form of d-AMD, because no treatment can restore the damage of retinal pigment epithelium (RPE) or photoreceptors. For this reason, al  ...[more]

Similar Datasets

| S-EPMC4388086 | biostudies-literature
| S-EPMC9414333 | biostudies-literature
| S-EPMC5472449 | biostudies-other
| S-EPMC5573066 | biostudies-literature
| S-EPMC5399962 | biostudies-literature
| S-EPMC3753825 | biostudies-literature
| S-EPMC5683729 | biostudies-literature
| S-EPMC10740940 | biostudies-literature
| S-EPMC3864379 | biostudies-literature
| S-EPMC4204600 | biostudies-literature